AlzChem AG   Report issue

For profit Phase 2
Founded: Munich Germany (1895)
Status: No NME R&D (1895)

Organization Overview

First Clinical Trial
2009
NCT00851006
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

AlzChem, LLC